The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.

di Fosså, S. D., Waehre, H., Paus, E.
Pubblicazione 1992

Late recurrences of germ cell malignancies: a population-based experience over three decades

di Oldenburg, J, Alfsen, G C, Wæhre, H, Fosså, S D
Pubblicazione 2006

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.

di Berner, A., Nesland, J. M., Waehre, H., Silde, J., Fosså, S. D.
Pubblicazione 1993

DNA ploidy in primary testicular cancer.

di Fosså, S. D., Nesland, J. M., Pettersen, E. O., Amellem, O., Waehre, H., Heimdal, K.
Pubblicazione 1991

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection

di Jacobsen, K D, Ous, S, Wæhre, H, Trasti, H, Stenwig, A E, Lien, H H, Aass, N, Fosså, S D
Pubblicazione 1999

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

di Mu, L J, Kyte, J A, Kvalheim, G, Aamdal, S, Dueland, S, Hauser, M, Hammerstad, H, Waehre, H, Raabe, N, Gaudernack, G
Pubblicazione 2005

Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.

di Fosså, S. D., Berner, A. A., Jacobsen, A. B., Waehre, H., Kvarstein, B., Urnes, T., Ogreid, P., Johansen, T. E., Silde, J., Nesland, J. M.
Pubblicazione 1993